Forum

Based on this assay platform, CD Bioparticles has developed dozens of clinically relevant tests, including those for infectious disease biomarkers, serum tumour markers, thyroid function-related hormones, reproductive hormones and cardiac emergency markers. CD Bioparticles provides comprehensive solutions ranging from homogeneous assay raw materials to technical development and large-scale production. Leveraging extensive experience in innovative R&D and mass production, CD Bioparticles assists clients in developing homogeneous, chemiluminescence-based products, thereby reducing development costs and shortening R&D cycles.